Physician-scientists at the Icahn School of Medicine at Mount Sinai launched a series of clinical trials to test promising treatments for gynecologic cancers, including antibody-drug conjugates, a new and highly targeted approach.
Physician-scientists at the Icahn School of Medicine at Mount Sinai launched a series of clinical trials to test promising treatments for gynecologic cancers, including antibody-drug conjugates, a new and highly targeted approach.
